Search research articles
Contact Us
Filters
Showing results (371-380 of 457) with videos related to
Page
of 46
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
April 10, 2010
Baseline serum testosterone in men treated with androgen deprivation therapy and radiotherapy for localized prostate cancer
Mack Roach, Kyounghwa Bae, Colleen Lawton, et al.
European Urology
|
November 23, 2013
A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial
James S Wysock, Andrew B Rosenkrantz, William C Huang, et al.
Elife
|
November 8, 2021
The role of TAp63γ and P53 point mutations in regulating DNA repair, mutational susceptibility and invasion of bladder cancer cells
Hsiang-Tsui Wang, Hyun-Wook Lee, Mao-Wen Weng, et al.
Translational Andrology and Urology
|
May 8, 2018
Health state utilities among contemporary prostate cancer patients on active surveillance
Stacy Loeb, Caitlin Curnyn, Dawn Walter, et al.
The Journal of Urology
|
August 24, 1999
Detection of circulating uroplakin-positive cells in patients with transitional cell carcinoma of the bladder
S M Li, Z T Zhang, S Chan, et al.
Urology
|
January 1, 1997
Smooth muscle development in the obstructed fetal bladder
A L Freedman, F Qureshi, E Shapiro, et al.
Human Pathology
|
August 21, 2007
Persistent uroplakin expression in advanced urothelial carcinomas: implications in urothelial tumor progression and clinical outcome
Hong-Ying Huang, Shahrokh F Shariat, Tung-Tien Sun, et al.
Developmental Biology
|
June 1, 2011
Differentiation of the ductal epithelium and smooth muscle in the prostate gland are regulated by the Notch/PTEN-dependent mechanism
Xinyu Wu, Kun Xu, Lixia Zhang, et al.
Cardiovascular Diabetology
|
August 7, 2019
Class effects of SGLT2 inhibitors on cardiorenal outcomes
Aaron Y Kluger, Kristen M Tecson, Andy Y Lee, et al.
Reviews in Cardiovascular Medicine
|
November 20, 2002
Design and rationale of CONTRAST--a prospective, randomized, placebo-controlled trial of fenoldopam mesylate for the prevention of radiocontrast nephropathy
G W Stone, J A Tumlin, H Madyoon, et al.
Page
of 46
Search research articles
Search
Showing results (371-380 of 457) with videos related to
Sort By:
Page
of 46
International Journal of Radiation Oncology, Biology, Physics
|
April 10, 2010
Baseline serum testosterone in men treated with androgen deprivation therapy and radiotherapy for localized prostate cancer
Mack Roach, Kyounghwa Bae, Colleen Lawton, et al.
European Urology
|
November 23, 2013
A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial
James S Wysock, Andrew B Rosenkrantz, William C Huang, et al.
Elife
|
November 8, 2021
The role of TAp63γ and P53 point mutations in regulating DNA repair, mutational susceptibility and invasion of bladder cancer cells
Hsiang-Tsui Wang, Hyun-Wook Lee, Mao-Wen Weng, et al.
Translational Andrology and Urology
|
May 8, 2018
Health state utilities among contemporary prostate cancer patients on active surveillance
Stacy Loeb, Caitlin Curnyn, Dawn Walter, et al.
The Journal of Urology
|
August 24, 1999
Detection of circulating uroplakin-positive cells in patients with transitional cell carcinoma of the bladder
S M Li, Z T Zhang, S Chan, et al.
Urology
|
January 1, 1997
Smooth muscle development in the obstructed fetal bladder
A L Freedman, F Qureshi, E Shapiro, et al.
Human Pathology
|
August 21, 2007
Persistent uroplakin expression in advanced urothelial carcinomas: implications in urothelial tumor progression and clinical outcome
Hong-Ying Huang, Shahrokh F Shariat, Tung-Tien Sun, et al.
Developmental Biology
|
June 1, 2011
Differentiation of the ductal epithelium and smooth muscle in the prostate gland are regulated by the Notch/PTEN-dependent mechanism
Xinyu Wu, Kun Xu, Lixia Zhang, et al.
Cardiovascular Diabetology
|
August 7, 2019
Class effects of SGLT2 inhibitors on cardiorenal outcomes
Aaron Y Kluger, Kristen M Tecson, Andy Y Lee, et al.
Reviews in Cardiovascular Medicine
|
November 20, 2002
Design and rationale of CONTRAST--a prospective, randomized, placebo-controlled trial of fenoldopam mesylate for the prevention of radiocontrast nephropathy
G W Stone, J A Tumlin, H Madyoon, et al.
Page
of 46